Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Pure Red Cell Aplasia after ABO Incompatible Hematopoietic Stem Cell Transplantation Successfully Treated with Daratumumab: A Case Report

Amaal Gulied, Afraa Mustafa Sulieman Fadul, Sharon Jacob, Dina Sameh Soliman, Ibrahim Ganwo, Amna Gameil, Anas Ahmad Hamad, Mohammad Bakr, Javid Gaziev

Blood (2024) 144 (Supplement 1): 7406.

https://doi.org/10.1182/blood-2024-211805

Published: 2024

Journal Articles

Experience of Plerixafor Use for Autologous Stem Cell Mobilization in Qatar: A Single Center Experience

Amaal Gulied, Farah Imadeldeen Jibril, Rola Ghasoub, Aya Alasmar, Yahya Mulikandathil, Afraa Mustafa Sulieman Fadul, Amna Gameil, Manal Yaghmour, Wedad Saleem, Fabio Culurgioni, Saloua Hmissi, Shereen Elazzazy, Anas Ahmad Hamad, Javid Gaziev, Mohammad Bakr

Blood (2024) 144 (Supplement 1): 7123.

https://doi.org/10.1182/blood-2024-212076

Published: 2024

Journal Articles

Age Is a Crucial Determinant of GFRS with Incidence of Severe Chronic GVHD Reducing over Time in Haemopoietic Cell Transplantation for Transfusion Dependent Thalassaemia: Real World Data from 2010-2021. an Analysis of the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Working Party

Donatella Baronciani, Josu de la Fuente, Jacques-Emanuel Galimard, Arnaud Dalissier, Ashrafsadat Mousavi, Akif Yesilipek, Hasan Hashem, Gulyuz Ozturk, Franco Locatelli, Ali Alahmari, Javid Gaziev, Ali Bülent Antmen, O. Alphan Kupesiz, Tunc Fisgin, Giorgio La Nasa, Arjan C. Lankester, Eugene Goussetis, Sandrine Bremathas, Emanuele Angelucci

Blood (2024) 144 (Supplement 1): 2136.

https://doi.org/10.1182/blood-2024-208421

Published: 2024

Journal Articles

Allogeneic Transplantation for Sickle Cell Disease Offers High Rates of Cure with Low Incidence of Severe Chronic GVHD in Both Children and Adults: Real World Data from 2010-2021. An Analysis of the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Working Party

Blood (2024) 144 (Supplement 1): 176.

https://doi.org/10.1182/blood-2024-207944

Published: 2024

Journal Articles

Significant Growth in HCT Use for Haemoglobinopathies in the Last Decade Driven By Sickle Cell Disease across All Ages with Excellent Outcomes: An Analysis of EBMT Haemoglobinopathies Working Party

Blood (2024) 144 (Supplement 1): 2184.

https://doi.org/10.1182/blood-2024-208191

Published: 2024

Journal Articles

Clinically Significant CMV Infection in Allogeneic Stem-Cell Transplant Recipients: A Single Center Experience

Amaal Gulied, Aya Alasmar, Mohammad Bakr, Hawra Shawayli, Rola Ghasoub, Afraa Mustafa Sulieman Fadul, Amna Gameil, Deena SIDEEG Mudawi, Anas Ahmad Hamad, Javid Gaziev

Blood (2023) 142 (Supplement 1): 6986.

https://doi.org/10.1182/blood-2023-189903

Published: 2023

Journal Articles

Establishment of a Clinical Pharmacist-Led Multiple Myeloma Clinic with Collaborative Prescribing Model at the National Center for Cancer Care and Research in Qatar

Rola Ghasoub, Shereen Elazzazy, Maria Benkhadra, Nancy Kassem, Honar Cherif, Javid Gaziev, Hesham Elsabah, Anas Ahmad Hamad

Blood (2023) 142 (Supplement 1): 5079.

https://doi.org/10.1182/blood-2023-185615

Published: 2023

Journal Articles

Transplant Associated Thrombotic Microangiopathy: Acomprehensive Review and Local Experience

Maria Benkhadra, Amaal Gulied, Mohamed Saeed Mohamed, Deena Mudawi, Javid Gaziev, Murtadha Al-Khabori, Mohamed A Yassin

Blood (2023) 142 (Supplement 1): 7116.

https://doi.org/10.1182/blood-2023-184374

Published: 2023

Journal Articles

Hematopoietic Cell Transplantation in Thalassemia and Sickle Cell Disease: Report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry: 2000-2017

Donatella Baronciani, MD, Ariane Boumendil, PhD, Arnaud Dalissier, PhD, Javid Gaziev, Ardeshir Ghavamzadeh, MD, Josu de la Fuente, FRCP, PhD FRCPath, Marco Zecca, MD, Amal Al-Seraihy, MD, O. Alphan Kupesiz, MD, Abdelghani Tbakhi, MD, Gerard Socie, MD PhD, Vassiliki Kitra-Roussou, MD, Arjan Lankester, MD PhD, Gian Luca Forni, MD, Peter Bader, MD PhD, Emanuele Angelucci, MD

Blood (2018) 132 (Supplement 1): 168.

https://doi.org/10.1182/blood-2018-168

Published: 2018

Journal Articles

Outcomes of Unrelated Bone Marrow Transplantation in Patients with Thalassemia

Javid Gaziev, Antonella Isgro, MD, Katia Paciaroni, MD, Marco Marziali, MD, Gioia De Angelis, MD, Michela Ribersani, MD, Cecilia Alfieri, MD, Marco Andreani, PhD

Blood (2018) 132 (Supplement 1): 5777.

https://doi.org/10.1182/blood-2018-99-109764

Published: 2018

Journal Articles

Long-Term Outcome after Haploidentical Hematopoietic Cell Transplantation Utilizing CD34+ Selected/CD3CD19+ Depleted or Tcrαβ+/CD19+ Depleted Grafts in Pediatric Patients with Hemoglobinopathies

Javid Gaziev, Antonella Isgrò, MD, Pietro Sodani, MD, Katia Paciaroni, MD, Gioia De Angelis, MD, Marco Marziali, MD, Michela Ribersani, MD, Cecilia Alfieri, MD, Marco Andreani, PhD, Tiziana Gallucci, PhD, Guido Lucarelli, MD

Blood (2017) 130 (Supplement 1): 663.

https://doi.org/10.1182/blood.V130.Suppl_1.663.663

Published: 2017

Journal Articles

Evaluation of the Impact of Anti-Thymocyte Globulin on Post-Transplant Outcomes in Sickle Cell Anemia Patients Undergoing BMT from HLA-Identical Sibling Donors

Javid Gaziev, MD, Antonella Isgro, MD, Marco Marziali, MD, Katia Paciaroni, MD, Gioia De Angelis, MD, Marco Andreani, PhD, Cecilia Alfieri, MD, Michela Ribersani, MD, Guido Lucarelli, MD

Blood (2016) 128 (22): 3468.

https://doi.org/10.1182/blood.V128.22.3468.3468

Published: 2016

Journal Articles

Optimal Outcomes after Second Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Recurrence Following Graft Failure/Rejection of the First Graft

Javid Gaziev, MD, Katia Paciaroni, MD, Gioia De Angelis, MD, Antonella Isgro, MD, Marco Marziali, MD, Marco Andreani, PhD, Cecilia Alfieri, MD, Michela Ribersani, MD, Guido Lucarelli, MD

Blood (2016) 128 (22): 2289.

https://doi.org/10.1182/blood.V128.22.2289.2289

Published: 2016

Journal Articles

Hematopoietic Stem Cell Transplantation in Nigerian Children with Sickle Cell Anemia

Antonella Isgro, MD, Javid Gaziev, Pietro Sodani, MD, Marco Andreani, PhD, Manuela Testi, PhD, Katia Paciaroni, MD, Cristiano Gallucci, MD, Gioia De Angelis, MD, Marco Marziali, MD, Cecilia Alfieri, MD, Michela Ribersani, MD, Olufemi O Akinyanju, T. Thompson Wakama, Festus Olusola Olowoselu, Guido Lucarelli, MD

Blood (2015) 126 (23): 4598.

https://doi.org/10.1182/blood.V126.23.4598.4598

Published: 2015

Journal Articles

Transplant Outcomes in High-Risk (Class 3) Patients with Thalassemia Treated with a Modified Protocol Are Equivalent to Low/Intermediate-Risk (Class 1/Class 2) Patients

Javid Gaziev, MD, Gioia De Angelis, MD, Antonella Isgro, MD, Pietro Sodani, MD, Marco Marziali, MD, Katia Paciaroni, MD, Marco Andreani, PhD, Manuela Testi, PhD, Cristiano Gallucci, MD, Cecilia Alfieri, MD, Michela Ribersani, MD, Maria Troiano, PhD, Aldo Morrone, MD, Guido Lucarelli, MD

Blood (2015) 126 (23): 620.

https://doi.org/10.1182/blood.V126.23.620.620

Published: 2015

Journal Articles

Bone Marrow Transplantation For Thalassemia Using Related Other Than HLA- Identical Siblings: Improved Transplant Outcomes With a Novel Approach

Javid Gaziev, Marco Marziali, Antonella Isgro, Pietro Sodani, Katia Paciaroni, Cristiano Gallucci, Gioia De Angelis, Cecilia Alfieri, Marco Andreani, BSc, Manuela Testi, Michela Ribersani, Luisa Cardarelli, Daniele Armiento, Guido Lucarelli

Blood (2013) 122 (21): 2040.

https://doi.org/10.1182/blood.V122.21.2040.2040

Published: 2013

Journal Articles

Outcome Of Bone Marrow Transplantation In Lebanese Children With β-Thalassemia Major

Adlette Inati, MD, Javid Gaziev, MD, Hussein A Abbas, PhD, Serge Korjian, BSc, Yazan Daaboul, BSc, Mario Kahale, MD, Katia Paciaroni, MD, Gioia de Angelis, MD, Ali T Taher, MD, Therese Abi Nasr, MD, Suzan Koussa, MD, Guido Lucarelli, MD

Blood (2013) 122 (21): 5505.

https://doi.org/10.1182/blood.V122.21.5505.5505

Published: 2013

Journal Articles

Bone marrow transplantation for thalassemia from alternative related donors: improved outcomes with a new approach

Javid Gaziev, Marco Marziali, Antonella Isgrò, Pietro Sodani, Katia Paciaroni, Cristiano Gallucci, Marco Andreani, Manuela Testi, Gioia De Angelis, Cecilia Alfieri, Luisa Cardarelli, Michela Ribersani, Daniele Armiento, Guido Lucarelli

Blood (2013) 122 (15): 2751–2756.

https://doi.org/10.1182/blood-2013-07-513473

Published: 2013

Journal Articles

Decreased Apoptosis in Bone Marrow of Pediatric Patients After HLA-Identical Stem Cell Transplantation for African Sickle Cell Anemia

Antonella Isgrò, Marco Marziali, Pietro Sodani, Javid Gaziev, MD, Daniela Fraboni, Katia Paciaroni, Maria Domenica Simone, Gioia De Angelis, Cecilia Alfieri, Cristiano Gallucci, Andrea Roveda, Fabio Torelli, Luisa Cardarelli, Michela Ribersani, Guido Lucarelli

Blood (2012) 120 (21): 4751.

https://doi.org/10.1182/blood.V120.21.4751.4751

Published: 2012

Journal Articles

Rapid Increase of CD8+ T Cell Count in Peripheral Blood of Pediatric Patients After HLA-Identical Stem Cell Transplantation for African Sickle Cell Anemia

Antonella Isgrò, Marco Marziali, Pietro Sodani, Javid Gaziev, Daniela Fraboni, Katia Paciaroni, Maria Domenica Simone, Gioia De Angelis, Cecilia Alfieri, Cristiano Gallucci, Andrea Roveda, Fabio Torelli, Luisa Cardarelli, Michela Ribersani, Guido Lucarelli

Blood (2012) 120 (21): 4769.

https://doi.org/10.1182/blood.V120.21.4769.4769

Published: 2012

NARROW

Pure Red Cell Aplasia after ABO Incompatible Hematopoietic Stem Cell Transplantation Successfully Treated with Daratumumab: A Case Report

Experience of Plerixafor Use for Autologous Stem Cell Mobilization in Qatar: A Single Center Experience

Allogeneic Transplantation for Sickle Cell Disease Offers High Rates of Cure with Low Incidence of Severe Chronic GVHD in Both Children and Adults: Real World Data from 2010-2021. An Analysis of the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Working Party

Significant Growth in HCT Use for Haemoglobinopathies in the Last Decade Driven By Sickle Cell Disease across All Ages with Excellent Outcomes: An Analysis of EBMT Haemoglobinopathies Working Party

Clinically Significant CMV Infection in Allogeneic Stem-Cell Transplant Recipients: A Single Center Experience

Establishment of a Clinical Pharmacist-Led Multiple Myeloma Clinic with Collaborative Prescribing Model at the National Center for Cancer Care and Research in Qatar

Transplant Associated Thrombotic Microangiopathy: Acomprehensive Review and Local Experience

Hematopoietic Cell Transplantation in Thalassemia and Sickle Cell Disease: Report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry: 2000-2017

Outcomes of Unrelated Bone Marrow Transplantation in Patients with Thalassemia

Long-Term Outcome after Haploidentical Hematopoietic Cell Transplantation Utilizing CD34+ Selected/CD3CD19+ Depleted or Tcrαβ+/CD19+ Depleted Grafts in Pediatric Patients with Hemoglobinopathies

Evaluation of the Impact of Anti-Thymocyte Globulin on Post-Transplant Outcomes in Sickle Cell Anemia Patients Undergoing BMT from HLA-Identical Sibling Donors

Optimal Outcomes after Second Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Recurrence Following Graft Failure/Rejection of the First Graft

Hematopoietic Stem Cell Transplantation in Nigerian Children with Sickle Cell Anemia

Transplant Outcomes in High-Risk (Class 3) Patients with Thalassemia Treated with a Modified Protocol Are Equivalent to Low/Intermediate-Risk (Class 1/Class 2) Patients

Bone Marrow Transplantation For Thalassemia Using Related Other Than HLA- Identical Siblings: Improved Transplant Outcomes With a Novel Approach

Outcome Of Bone Marrow Transplantation In Lebanese Children With β-Thalassemia Major

Bone marrow transplantation for thalassemia from alternative related donors: improved outcomes with a new approach

Decreased Apoptosis in Bone Marrow of Pediatric Patients After HLA-Identical Stem Cell Transplantation for African Sickle Cell Anemia

Rapid Increase of CD8+ T Cell Count in Peripheral Blood of Pediatric Patients After HLA-Identical Stem Cell Transplantation for African Sickle Cell Anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only